Efficacy and Safety of Sofosbuvir-Based Therapies in Pediatric Hepatitis C
A RECENT study has demonstrated the high efficacy and favorable safety profile of sofosbuvir-based regimens in treating hepatitis C virus (HCV) in children aged 5 to 17…

A RECENT study has demonstrated the high efficacy and favorable safety profile of sofosbuvir-based regimens in treating hepatitis C virus (HCV) in children aged 5 to 17…